Drug · DIN 02294591
LISINOPRIL
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since June 25, 2014; first marketed March 12, 2008.
- Drug Identification Number (DIN)
- 02294591
- Company (DIN owner)
- Meliapharm IncMontreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Lisinopril C09AA03
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LISINOPRIL | 10 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 16, 2010: NOC 11138Abbreviated New Drug Submission (ANDS) · Manufacturer and product name change
- October 17, 2007: NOC 9116Abbreviated New Drug Submission (ANDS) · New manufacturer and product name
Other DINs named LISINOPRIL
- DIN 02294583 · Cancelled Post Market
- DIN 02294605 · Cancelled Post Market
- DIN 02321580 · Cancelled Post Market
- DIN 02321610 · Cancelled Post Market
- DIN 02321629 · Cancelled Post Market
- DIN 02343576 · Cancelled Pre Market
- DIN 02343584 · Cancelled Pre Market
- DIN 02343592 · Cancelled Pre Market
- DIN 02386232 · Dormant
- DIN 02386240 · Dormant
- DIN 02386259 · Dormant
- DIN 02386267 · Cancelled Pre Market